TKM Changes Company Name to HK Bio Innovation
[Asia Economy Reporter Hyun-ui Cho] TK M, a biopharmaceutical subsidiary of Kolmar Holdings, will change its name to HK Bio Innovation.
On the 9th, HK Bio Innovation announced this and stated, "The new name embodies our determination to leap forward as a global biopharmaceutical company through innovative product development."
Based on over 20 years of accumulated expertise in biopharmaceutical research, development, and production, HK Bio Innovation plans to expand its scope beyond contract development and manufacturing organization (CDMO) services to include advanced biopharmaceutical development through active open innovation.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- EU Backs Down Under Trump’s Pressure: “Will Implement Trade Agreement”
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Lee Dong-eok, CEO of HK Bio Innovation, said, "We will take on new challenges to become a century-old company leading the global bio industry."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
